A Double Blind Clinical Trial of DCS for Food Anxiety
|ClinicalTrials.gov Identifier: NCT01996644|
Recruitment Status : Completed
First Posted : November 27, 2013
Last Update Posted : December 10, 2014
|Condition or disease||Intervention/treatment|
|Anorexia and Bulimia Nervosa||Drug: Sertaline|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||47 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||A Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa|
|Study Start Date :||February 2013|
|Primary Completion Date :||February 2014|
|Study Completion Date :||February 2014|
250 mg DCS (setraline) versus placebo
Placebo Comparator: placebo
- Anxiety [ Time Frame: Twice a week for two weeks ]Anxiety will be measured at 4 sessions, twice a week for two weeks.
- Body Mass Index [ Time Frame: twice a week for two weeks and at initial assessment ]BMI will be measured twice a week for two weeks and once before starting the trial.
- Fear of food [ Time Frame: Twice during 2 weeks ]Fear of food will be measured once before and after the trial.
- SUDS [ Time Frame: 2 weeks- twice a week ]SUDS will be measured twice a week for two weeks during trial.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01996644
|United States, Missouri|
|Saint Louis, Missouri, United States, 63130|